Haemonetics Corporation
10/08/2026 | Press release | Distributed by Public on 10/08/2026 04:15
Regulation FD Disclosure (Form 8-K)
Item 7.01 Regulation FD Disclosure
On August 18, 2026, Haemonetics Corporation (the "Company") furnished a Current Report on Form 8-K disclosing its entry into a non-exclusive supply agreement with CSL Plasma Inc. ("CSL"), under which CSL may utilize the Company's NexSys PCS® devices with Persona® PLUS technology and purchase related disposables in the United States. On October 8, 2026, CSL announced that it expects to complete the rollout of the Company's devices and disposables under the supply agreement by the end of calendar year 2027, and CSL has informed the Company that it currently anticipates that the transition to the Company's devices and disposables will occur at all of CSL's current U.S. plasma collection centers. The scope and timing of the rollout remain subject to change consistent with the terms of the supply agreement, and the implementation details for the rollout are still to be determined by CSL and the Company. Accordingly, the Company is not updating its previously issued fiscal 2027 guidance at this time. The Company expects to provide an update regarding the anticipated impact of the supply agreement on its fiscal 2027 financial results in connection with its second fiscal quarter earnings call in November 2026.
The foregoing information in this Item 7.01 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, regardless of any general incorporation language in such filing.
Haemonetics Corporation published this content on October 08, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on October 08, 2026 at 10:15 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]